Ang-2 is a potential molecular marker for lymphatic metastasis and better response to bevacizumab therapy in ovarian cancer.
Ang-2 是卵巢癌淋巴转移和对贝伐珠单抗治疗反应的潜在分子标志物
期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-023-05354-1
Volk Annabelle, Legler Karen, Hamester Fabienne, Kuerti Sascha, Eylmann Kathrin, Rossberg Maila, Schmalfeldt Barbara, Oliveira-Ferrer Leticia
